Try it
Anaesthesia · Special anaesthesia: hepatic disease
Sample itemWhich inhalational agent is best avoided in a patient with liver disease?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Halothane
Halothane reduces hepatic blood flow and undergoes about 20% hepatic metabolism, so it carries a risk of hepatitis. Isoflurane, sevoflurane and desflurane preserve hepatic blood flow better.
Option by option
A. Halothane (correct)
Correct. Halothane is avoided.
B. Sevoflurane
Sevoflurane has little hepatic metabolism.
C. Desflurane
Desflurane has minimal metabolism.
D. Isoflurane
Isoflurane preserves hepatic blood flow.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Anaesthesia questions
- Intravenous anaestheticsWhich intravenous anaesthetic agent typically increases heart rate and blood pressure?
- Regional anaesthesiaWhat is the definitive treatment for persistent post-dural puncture headache that does n…
- Inhalational anaestheticsWhich of the following inhalational agents has the lowest MAC, and so the highest potency?
- Pre-operative assessmentA patient with well-controlled mild hypertension and no functional limitation is classif…